Inventor · disambiguated record
Yuya Oguro
Also filed as: OGURO YUYA
18 granted patents·7 pending applications·50 citations·filing 2006–2024
91Inventor score
Top patents by PatentIndex Score
25 records- 0193US10610520B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
- 0293US10323026B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 18, 2019·20 cites·10 claims
- 0389US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 0487US11713311B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 1, 2023·1 cites·8 claims
- 0584US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 0684US8933069B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Granted Jan 13, 2015·5 cites·6 claims
- 0780US11827601B2Heterocyclic NMDA antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Nov 28, 2023·0 cites·8 claims
- 0879US8217176B2Fused heterocyclic derivative and use thereofOGURO YUYA·Filed 2009·Granted Jul 10, 2012·4 cites·4 claims
- 0978US11834409B2Heterocyclic NMDA antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Dec 5, 2023·0 cites·22 claims
- 1077US11230541B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 25, 2022·2 cites·12 claims
- 1172US8304557B2Fused heterocycle derivatives and use thereofOGURO YUYA·Filed 2008·Granted Nov 6, 2012·2 cites·6 claims
- 1267US8399449B2Fused heterocyclic derivative and use thereofFUJII NOBUHIRO·Filed 2009·Granted Mar 19, 2013·1 cites·16 claims
- 1364US9388195B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Granted Jul 12, 2016·0 cites·16 claims
- 1464US2023002318A1Heterocyclic nmda antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 1563US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1662US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1760US2017209452A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 1859US9655900B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted May 23, 2017·0 cites·8 claims
- 1952US11952344B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Apr 9, 2024·0 cites·5 claims
- 2046US10131653B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Nov 20, 2018·0 cites·12 claims
- 2144US11746109B2Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrateTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Sep 5, 2023·0 cites·20 claims
- 2243US2022089525A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 2343US2009137580A1Fused Heterocyclic Derivatives and Use ThereofTAKEDA PHARMACEUTICAL·Filed 2006·Application pending·0 cites
- 2436US2011034469A1Heterocyclic CompoundTAKEDA PHARMACEUTICAL·Filed 2010·Application pending·0 cites
- 2533US8691828B2Thienopyrimidine as CDC7 kinase inhibitorsOGURO YUYA·Filed 2010·Granted Apr 8, 2014·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Yuya Oguro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →